Boehringer Ingelheim: A Global Leader in Pharmaceutical InnovationBoehringer Ingelheim, a renowned multinational pharmaceutical company, has been at the forefront of medical innovation for over a cent...
Boehringer Ingelheim Equioxx is a brand name for firocoxib tablets that are used for horses suffering from pain and inflammation associated with osteoarthritis. Equioxx is a non-steroidal, anti-inflammatory medication that is administered orally and is only available with a prescription from a licensed veterinarian.
Equioxx is developed by Boehringer Ingelheim Animal Health , a subsidiary of Boehringer Ingelheim, a global pharmaceutical company headquartered in Germany. Boehringer Ingelheim Animal Health is dedicated to providing innovative animal health solutions to improve the health and well-being of animals.
Equioxx is designed with a targeted approach to inflammation. It is a selective inhibitor of cyclooxygenase-2 (COX-2), an enzyme responsible for producing inflammatory prostaglandins. By specifically targeting COX-2, Equioxx helps to reduce inflammation and pain while avoiding unwanted side effects such as gastric ulcers and kidney toxicity.
The recommended dosage for Equioxx may vary depending on the horse's weight and condition. It is important to follow the dosage instructions provided by the veterinarian and to administer the medication exactly as prescribed.
Boehringer Ingelheim Equioxx is available for purchase through licensed veterinarians and animal health suppliers. Boehringer Ingelheim Animal Health offers various rebate programs that consumers can participate in to save on their Equioxx purchase. If you have further questions about Equioxx or any other Boehringer Ingelheim products, you can visit their website or contact their customer service.